lorcaserin

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
Xconomy
Eisai
lorcaserin
Belviq
cancer
FDA
weight loss
Flag link:
Arena - Anti-Obesity Drug Lorcaserin Approved In Mexico
Arena - Anti-Obesity Drug Lorcaserin Approved In Mexico
Seeking Alpha
Arena Pharmaceuticals
lorcaserin
obesity
Mexico
Flag link:
Why Biotechs Arena And Vivus Will Grow While People Shrink
Why Biotechs Arena And Vivus Will Grow While People Shrink
Seeking Alpha
Arena
Vivus
obesity
weight loss
Qnexa
lorcaserin
Flag link:
Obesity Drug Stocks Go Wild After Belviq Approval
Obesity Drug Stocks Go Wild After Belviq Approval
Investors.com
obesity
lorcaserin
Belviq
Arena Pharmaceuticals
Orexigen
Vivus
Flag link:
Arena’s Weight-Loss Pill Approved By U.S. Regulators
Arena’s Weight-Loss Pill Approved By U.S. Regulators
Bloomberg
Arena
obesity
FDA
lorcaserin
Belviq
Flag link:
Vivus and Arena: A Tale of Dueling FDA Panel Minutes
Vivus and Arena: A Tale of Dueling FDA Panel Minutes
TheStreet.com
Vivus
Arena Pharmaceuticals
obesity
FDA
lorcaserin
Qnexa
Flag link:
Arena Pharma And The Fat Lady's Song
Arena Pharma And The Fat Lady's Song
TheStreet.com
Arena Pharmaceuticals
lorcaserin
obesity
Flag link:
No Delay for Arena?
No Delay for Arena?
Motley Fool
Arena Pharmaceuticals
lorcaserin
obesity
weight loss
Flag link:
Arena Sold Out? (video)
Arena Sold Out? (video)
CNBC
Arena Pharmaceuticals
lorcaserin
obesity
weight loss
Flag link:
Arena Declines As Column Warns Of Crash After 10-Day Run
Arena Declines As Column Warns Of Crash After 10-Day Run
Bloomberg
Arena Pharmaceuticals
lorcaserin
obesity
weight loss
Flag link:
Will Patience Pay for Arena’s Biggest Fans Awaiting the Final Answer?
Will Patience Pay for Arena’s Biggest Fans Awaiting the Final Answer?
Wall Street Cheat Street
Arena
lorcaserin
obesity
weight loss
Flag link:
Why are Obesity Stocks Suddenly So Hot?
Why are Obesity Stocks Suddenly So Hot?
Motley Fool
obesity
lorcaserin
Arena Pharmaceuticals
Vivus
Qnexa
Orexigen
Contrave
Flag link:
Arena shares slump 14 pct before diet drug ruling
Arena shares slump 14 pct before diet drug ruling
Reuters
Arena Pharmaceuticals
lorcaserin
FDA
obesity
Flag link:
Are Arena Pharma’s Heaviest Stockholders Buying Shares Ahead of the Weight Loss Drug Decision?
Are Arena Pharma’s Heaviest Stockholders Buying Shares Ahead of the Weight Loss Drug Decision?
Wall St. Cheat Sheet
FDA
Arena Pharmaceuticals
lorcaserin
Flag link:
Qnexa Has Brighter Prospects Than Contrave, Lorcaserin
Qnexa Has Brighter Prospects Than Contrave, Lorcaserin
Motley Fool
obesity
Qnexa
Contrave
lorcaserin
Vivus
Orexigen
Arena Pharmaceuticals
Flag link:
4 Companies With Upcoming Drug Approval Dates With 1 Potential Buyout Looming
4 Companies With Upcoming Drug Approval Dates With 1 Potential Buyout Looming
Seeking Alpha
Onyx
Carfilzomib
Arena Pharmaceuticals
lorcaserin
Vivus
Qnexa
AMR101
Amarin
Obagi Medical Products
Flag link:
Arena Pharmaceuticals: Rising Star Or Falling Knife?
Arena Pharmaceuticals: Rising Star Or Falling Knife?
Seeking Alpha
Arena Pharmaceuticals
obesity
lorcaserin
Contrave
Qnexa
Orexigen
Vivus
Flag link:
Arena Trading Surges Ahead of Key FDA Drug Approval Decision
Arena Trading Surges Ahead of Key FDA Drug Approval Decision
TheStreet.com
Arena Pharmaceuticals
FDA
obesity
lorcaserin
Flag link:
Diet Pill Maker Orexigen Sees Room for Three Rivals
Diet Pill Maker Orexigen Sees Room for Three Rivals
Minyanville
Orexigen
Arena Pharmaceuticals
Vivus
lorcaserin
Qnexa
Contrave
Flag link:
Orexigen Calls Dr. Nissen
Orexigen Calls Dr. Nissen
Forbes
Orexigen
obesity
Steve Nissen
Contrave
Vivus
Arena
lorcaserin
Cleveland Clinic
Flag link:

Pages